Fennec Pharmaceuticals Inc. (TSE:FRX) Director Chris Anigeron Rallis Sells 1,119 Shares
MarketBeat
Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Chris Anigeron Rallis sold 1,119 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of C$11.93, for a total transaction of C$13,352.69.
TSE:FRX